First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT05527184 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer
High Grade Serous Adenocarcinoma of Ovary
Primary Peritoneal Carcinoma
Fallopian Tube Cancer
Cervical Cancer

Interventions

DRUG: IMGN151

Sponsor

AbbVie